TMCnet - World's Largest Communications and Technology Community



Research and Markets: Global Cardiovascular Disorders Drug Pipeline Capsule - 2012
[December 11, 2012]

Research and Markets: Global Cardiovascular Disorders Drug Pipeline Capsule - 2012

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "Global Cardiovascular Disorders Drug Pipeline Capsule - 2012" report to their offering.

Fore Pharma's latest report Global Cardiovascular Disorders Drug Pipeline Capsule - 2012' provides up-to-date information on key research and development activities in the global cardiovascular disorders drug market. It covers active pipeline molecules under development in various stages of clinical trials, preclnical research, and drug discovery for Acute Coronary Syndrome, Hypertension, Myocardial Infarction, Pulmonary Hypertension, Stroke, and Thrombosis.

This report helps executives track their competitor's pipeline molecules. The information presented in this report can be used for identifying partners, evaluating business opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company, mechanism of action, stage (phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and drug discovery), and geography (North America, Europe, and Asia).

Key Features of the Report:

- Cardiovascular Disorders Drug Pipeline Insights

- Acute Coronary Syndrome Drug Pipeline Insights

- Hypertension Drug Pipeline Insights

- Myocardial Infarction Drug Pipeline Insights

- Pulmonary Hypertension Drug Pipeline Insights

- Stroke Drug Pipeline Insights

- Thrombosis Drug Pipeline Insights

For more information visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy